Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine C G Egberts

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|January 8, 2011
[Separate pharmaceutical budgets: skating on thin ice]Antoine C G Egberts, Anthonius de Boer
Pharmacoepidemiology and Drug Safety|February 24, 2006
Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the NetherlandsHelga Gardarsdottir, Eibert R Heerdink, Antoine C G Egberts
Journal of Clinical Psychopharmacology|April 25, 2006
The association between cytochrome P450-2D6 genotype and prescription of antiparkinsonian drugs in hospitalized psychiatric patients using antipsychotics: a retrospective follow-up studyHans Mulder, Frederik W Wilmink, Svetlana V Belitser, et al.
Drug Safety|June 20, 2002
Use of measures of disproportionality in pharmacovigilance: three Dutch examplesAntoine C G Egberts, Ronald H B Meyboom, Eugène P van Puijenbroek
Drug Safety|July 29, 2006
Clinical risk management in Dutch community pharmacies: the case of drug-drug interactionsHenk Buurma, Peter A G M De Smet, Antoine C G Egberts
Drug Safety|June 20, 2002
Signal selection and follow-up in pharmacovigilanceRonald H B Meyboom, Marie Lindquist, Antoine C G Egberts, et al.
The Annals of Pharmacotherapy|September 15, 2005
Disease and intolerability documentation in electronic patient recordsHenk Buurma, Peter A G M De Smet, Martine Kruijtbosch, et al.
The Annals of Pharmacotherapy|November 1, 2007
Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmaciesHenk Buurma, Tom Schalekamp, Antoine C G Egberts, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 9, 2003
Less medication switching after initial start with atypical antipsychoticsGerard W K Hugenholtz, Eibert R Heerdink, Willem A Nolen, et al.
Pharmacy World & Science : PWS|March 13, 2009
Reliability of the medication appropriateness index in Dutch residential homeClementine C M Stuijt, Eric J F Franssen, Antoine C G Egberts, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Nederlands Tijdschrift Voor Geneeskunde|January 8, 2011
[Separate pharmaceutical budgets: skating on thin ice]Antoine C G Egberts, Anthonius de Boer
Pharmacoepidemiology and Drug Safety|February 24, 2006
Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the NetherlandsHelga Gardarsdottir, Eibert R Heerdink, Antoine C G Egberts
Journal of Clinical Psychopharmacology|April 25, 2006
The association between cytochrome P450-2D6 genotype and prescription of antiparkinsonian drugs in hospitalized psychiatric patients using antipsychotics: a retrospective follow-up studyHans Mulder, Frederik W Wilmink, Svetlana V Belitser, et al.
Drug Safety|June 20, 2002
Use of measures of disproportionality in pharmacovigilance: three Dutch examplesAntoine C G Egberts, Ronald H B Meyboom, Eugène P van Puijenbroek
Drug Safety|July 29, 2006
Clinical risk management in Dutch community pharmacies: the case of drug-drug interactionsHenk Buurma, Peter A G M De Smet, Antoine C G Egberts
Drug Safety|June 20, 2002
Signal selection and follow-up in pharmacovigilanceRonald H B Meyboom, Marie Lindquist, Antoine C G Egberts, et al.
The Annals of Pharmacotherapy|September 15, 2005
Disease and intolerability documentation in electronic patient recordsHenk Buurma, Peter A G M De Smet, Martine Kruijtbosch, et al.
The Annals of Pharmacotherapy|November 1, 2007
Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmaciesHenk Buurma, Tom Schalekamp, Antoine C G Egberts, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 9, 2003
Less medication switching after initial start with atypical antipsychoticsGerard W K Hugenholtz, Eibert R Heerdink, Willem A Nolen, et al.
Pharmacy World & Science : PWS|March 13, 2009
Reliability of the medication appropriateness index in Dutch residential homeClementine C M Stuijt, Eric J F Franssen, Antoine C G Egberts, et al.
Pageof 10